Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter
- 31 December 1992
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 43 (4), 1135-1142
- https://doi.org/10.1016/0091-3057(92)90493-y
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopaminePharmacology Biochemistry and Behavior, 1991
- Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3h]btcp, a phencyclidine derivative) binding to the dopamine uptake complexNeuropharmacology, 1991
- Genetic Determinants of Suceptability to the Rewarding and Other Behavioral Actions of CocaineJournal of Addictive Diseases, 1991
- Synthesis of high specific activity (3,4-[3H]cyclohexyl)-N-[1 (2-benzo[b]thienyl)cyclohexyl]piperidine {[3H]BTCP}: A selective probe for the dopamine-reuptake complexJournal of Labelled Compounds and Radiopharmaceuticals, 1991
- Accelerated communication GBR-12909 and fluspirilene potently inhibited binding of [3H] (+) 3-PPP to sigma receptors in rat brainLife Sciences, 1990
- Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathwaysNeuropharmacology, 1990
- The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric studyBrain Research, 1990
- In vivo microdialysis and thermospray tandem mass spectrometry of the dopamine uptake blocker 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR-12909)Analytical Chemistry, 1990
- Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of CocaineScience, 1987
- Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine systemPsychopharmacology, 1981